Todays Market Nifty 8673.25 (+49.20) (+0.57%) Sensex 28123.44 (+118.07) (+0.42%)

Government slaps Rs-2500 crore  additional penalty on Reliance Industries

Government has slapped an additional penalty of US $380 million (around Rs 2,500 crore) on Reliance Industries and its partners for producing less than targeted natural gas from eastern offshore KG-D6 fields.

With this, the total penalty, which is in form of disallowing recovery of cost incurred, for missing the target in five fiscal years beginning April 1, 2010, now stands at a cumulative US $ 2.76 billion.

Lupin tops most reputed pharma brand list

Domestic pharma majors Lupin, Sun Pharma and Ciplahave dominated the list of top reputed pharmaceuticals brand survey released today. 

City-based Lupin Pharmaceuticals tops in reputation leading the country's most reputed pharmaceutical brands' list, as per 'Top Most Reputed Pharmaceutical Brand' study conducted by BlueBytes in association with TRA Research.

Sun Pharmaceutical, with a 52 per cent Brand Rep Score and Cipla with 28 per cent bagged the second and third spots, followed by Dr Reddy's Laboratories at fourth. 

Among global brands, GSK led the way, followed by Pfizerand Abbott. In all, 41 domestic and 17 international pharmaceutical brands were listed in the study. 

"India's reputation as the largest producer of generic drugs in the world has become vulnerable in light of the changing patent regime in the country. Reports say that by 2020,India is likely to be among the top three pharmaceutical markets by incremental growth and sixth largest market globally in absolute size," said Pooja Kaura, chief spokesperson for India's Most Reputed Brands